Bill Text: VA SB321 | 2012 | Regular Session | Enrolled
Bill Title: Prescription Monitoring Program; disclosures.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Passed) 2012-03-01 - Governor: Acts of Assembly Chapter text (CHAP0071) [SB321 Detail]
Download: Virginia-2012-SB321-Enrolled.html
Be it enacted by the General Assembly of Virginia: 1. That §§ 54.1-2521, 54.1-2523, 54.1-2523.1, and 54.1-2523.2 of the Code of Virginia are amended and reenacted as follows: §54.1-2521. Reporting requirements. A. The failure by any person subject to the reporting requirements set forth in this section and the Department's regulations to report the dispensing of covered substances shall constitute grounds for disciplinary action by the relevant health regulatory board. B. Upon dispensing a covered substance, a dispenser of such covered substance shall report the following information: 1. The recipient's name and address. 2. The recipient's date of birth. 3. The covered substance that was dispensed to the recipient. 4. The quantity of the covered substance that was dispensed. 5. The date of the dispensing. 6. The prescriber's identifier number. 7. The dispenser's identifier number. 8. The method of payment for the prescription. 9. Any other non-clinical information that is designated by the Director as necessary for the implementation of this chapter in accordance with the Department's regulations.
C. The reports required herein shall be made and transmitted in such manner and format and according to the standards and schedule established in the Department's regulations. §54.1-2523. Confidentiality of data; disclosure of information; discretionary authority of Director. A. All data, records, and reports relating to the prescribing and dispensing of covered substances to recipients and any abstracts from such data, records, and reports that are in the possession of the Prescription Monitoring program pursuant to this chapter and any material relating to the operation or security of the program shall be confidential and shall be exempt from the Virginia Freedom of Information Act (§2.2-3700 et seq.) pursuant to subdivision 15 of §2.2-3705.5. Further, the Director shall only have discretion to disclose any such information as provided in subsections B and C. B. Upon receiving a request for information in accordance with the Department's regulations and in compliance with applicable federal law and regulations, the Director shall disclose the following: 1. Information relevant to a specific investigation of a specific recipient or of a specific dispenser or prescriber to an agent designated by the superintendent of the Department of State Police to conduct drug diversion investigations pursuant to §54.1-3405. 2. Information relevant to an investigation or inspection of
or allegation of misconduct by a specific person licensed, certified, or
registered by or an applicant for licensure, certification, or registration by
a health regulatory board; information relevant to a disciplinary proceeding
before a health regulatory board or in any subsequent trial or appeal of an
action or board order to designated employees of the Department of Health
Professions; or to designated persons operating the Health Practitioners'
Monitoring Program pursuant to Chapter 25.1 (§54.1-2515 et seq.) 3. Information relevant to the proceedings of any investigatory grand jury or special grand jury that has been properly impaneled in accordance with the provisions of Chapter 13 (§19.2-191 et seq.) of Title 19.2. 4. Information relevant to a specific investigation of a
specific recipient, dispenser, or C. In accordance with the Department's regulations and applicable federal law and regulations, the Director may, in his discretion, disclose: 1. Information in the possession of the program concerning a recipient who is over the age of 18 to that recipient. 2. Information on a specific recipient to a prescriber, as defined in this chapter, for the purpose of establishing the treatment history of the specific recipient when such recipient is either under care and treatment by the prescriber or the prescriber is initiating treatment of such recipient. In a manner specified by the Director in regulation, notice shall be given to patients that information may be requested by the prescriber from the Prescription Monitoring Program. 3. Information on a specific recipient to a dispenser for the purpose of establishing a prescription history to assist the dispenser in determining the validity of a prescription in accordance with §54.1-3303 when the recipient is seeking a covered substance from the dispenser or the facility in which the dispenser practices. In a manner specified by the Director in regulation, notice shall be given to patients that information may be requested by the dispenser from the Prescription Monitoring Program. 4. Information relevant to an investigation or regulatory proceeding of a specific dispenser or prescriber to other regulatory authorities concerned with granting, limiting or denying licenses, certificates or registrations to practice a health profession when such regulatory authority licenses such dispenser or prescriber or such dispenser or prescriber is seeking licensure by such other regulatory authority. 5. Information relevant to an investigation relating to a specific dispenser or prescriber who is a participating provider in the Virginia Medicaid program or information relevant to an investigation relating to a specific recipient who is currently eligible for and receiving or who has been eligible for and has received medical assistance services to the Medicaid Fraud Control Unit of the Office of the Attorney General or to designated employees of the Department of Medical Assistance Services, as appropriate. 6. Information relevant to determination of the cause of death of a specific recipient to the designated employees of the Office of the Chief Medical Examiner. 7. Information for the purpose of bona fide research or education to qualified personnel; however, data elements that would reasonably identify a specific recipient, prescriber, or dispenser shall be deleted or redacted from such information prior to disclosure. Further, release of the information shall only be made pursuant to a written agreement between such qualified personnel and the Director in order to ensure compliance with this subdivision. D. The Director may enter into agreements for mutual exchange of information among prescription monitoring programs in other jurisdictions, which shall only use the information for purposes allowed by this chapter. E. This section shall not be construed to supersede the provisions of §54.1-3406 concerning the divulging of confidential records relating to investigative information. F. Confidential information that has been received, maintained or developed by any board or disclosed by the board pursuant to subsection A shall not, under any circumstances, be available for discovery or court subpoena or introduced into evidence in any medical malpractice suit or other action for damages arising out of the provision of or failure to provide services. However, this subsection shall not be construed to inhibit any investigation or prosecution conducted pursuant to Article 1 (§18.2-247 et seq.) of Chapter 7 of Title 18.2. §54.1-2523.1. Criteria for indicators of misuse; Director's authority to disclose information; intervention. The Director shall develop, in consultation with an advisory panel, criteria for indicators of misuse and a method for analysis of data collected by the Prescription Monitoring Program using the criteria for indicators of misuse. Upon the development of such criteria and data analysis, the Director may, in addition to the discretionary disclosure of information pursuant to §54.1-2523, disclose information using the criteria that indicates potential misuse by recipients of covered substances to (i) their specific prescribers for the purpose of intervention to prevent such misuse or abuse or (ii) an agent designated by the Superintendent of the Department of State Police for the purpose of an investigation into possible drug diversion. §54.1-2523.2. Authority to access database. Any prescriber authorized to access the information in the
possession of the Prescription Monitoring Program pursuant to this chapter may,
pursuant to regulations promulgated by the Director to implement the provisions
of this section, delegate such authority to |